Inhibition of Circulating Dipeptidyl Peptidase 4 Activity in Patients with Metastatic Prostate Cancer
Open Access
- 1 November 2014
- journal article
- research article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 13 (11) , 3082-3096
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (U24 CA126485, P50 CA92629-SPORE, R01 CA160816)
This publication has 71 references indexed in Scilit:
- Screening for Prostate Cancer: Early Detection or Overdetection?Annual Review of Medicine, 2012
- A High-Confidence Human Plasma Proteome Reference Set with Estimated Concentrations in PeptideAtlasMolecular & Cellular Proteomics, 2011
- Tumor markers in prostate cancer I: Blood-based markersActa Oncologica, 2011
- Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate‐specific antigen at or before age 50Cancer, 2010
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Monitoring peptidase activities in complex proteomes by MALDI-TOF mass spectrometryNature Protocols, 2009
- Peptidase substrates via global peptide profilingNature Chemical Biology, 2008
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Protein biomarker discovery and validation: the long and uncertain path to clinical utilityNature Biotechnology, 2006
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002